Informa’s (INF) “Buy” Rating Reaffirmed at Berenberg Bank

Berenberg Bank restated their buy rating on shares of Informa (LON:INF) in a research report released on Wednesday, Marketbeat Ratings reports. Berenberg Bank currently has a GBX 1,030 price target on the stock.

INF has been the topic of several other research reports. Panmure Gordon reaffirmed a “buy” rating and set a GBX 1,200 price objective on shares of Informa in a report on Wednesday, November 19th. Citigroup assumed coverage on Informa in a research report on Monday, January 12th. They issued a “neutral” rating and a GBX 975 target price for the company. JPMorgan Chase & Co. dropped their price target on Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating on the stock in a research note on Monday, January 12th. UBS Group reiterated a “buy” rating and issued a GBX 1,055 price objective on shares of Informa in a research note on Friday, November 7th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Informa from GBX 1,000 to GBX 1,140 and gave the company a “buy” rating in a report on Wednesday, October 29th. Six investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 1,094.29.

Informa Trading Up 1.7%

Shares of Informa stock opened at GBX 928 on Wednesday. The company has a current ratio of 0.56, a quick ratio of 1.70 and a debt-to-equity ratio of 31.98. The company has a fifty day simple moving average of GBX 905.85 and a 200-day simple moving average of GBX 901.22. The stock has a market cap of £11.87 billion, a price-to-earnings ratio of 168.73, a PEG ratio of 0.75 and a beta of 1.12. Informa has a 12-month low of GBX 634.20 and a 12-month high of GBX 1,000.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.